Efficacy of superficial and deep regional hyperthermia combined with systemic chemotherapy and radiotherapy in metastatic melanoma

JDDG - Journal of the German Society of Dermatology

Volumn 1, Issue 8, 2003, Pages 635-642

  Richtig, Erika ^a   Hoff, M ^a   Rehak, P ^a   Kapp, K ^a   Hofman Wellenhof, R ^a   Zalaudek, I ^a   Poschauko, J ^a   Uggowitzer, M ^a   Kohek, P ^a   Smolle, J ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Chemotherapy; Deep regional hyperthermia; Metastatic malignant melanoma; Radiotherapy; Superficial hyperthermia

Indexed keywords

CARBOPLATIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; LYMPH NODE METASTASIS; MALE; MELANOMA; RETROPERITONEAL CANCER; SKIN METASTASIS; CANCER STAGING; CHEMORADIOTHERAPY; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROCEDURES; RETROPERITONEAL NEOPLASMS; SECONDARY; SKIN NEOPLASMS; TREATMENT OUTCOME;

AGED; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; RETROPERITONEAL NEOPLASMS; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0141760285     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1610-0387.2003.03719.x     Document Type: Article

References (30)

1. Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, Garbe C. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Brit J Dermat 2002; 147: 62-70.
2. Slingluff CL, Stidham KR, Ricci WM, Stanley WE, Seigler HF. Surgical management of of regional lymph nodes in patients with melanoma. Experience with 4682 patients. Ann Surg 1994; 219: 120-130.
3. Kettelhack Ch, Schlag PM. Die isolierte Extremitätenperfusion beim malignen Melanom. In Garbe C, Dummer R, Kaufmann R, Tilgen W: Dermatologische Onkologie. Berlin: Springer Verlag, 1997: 358-368.
4. Tilgen W, Uhl K, Bröcker EB. Palliative Therapie des malignen Melanoms. In Garbe C, Dummer R, Kaufmann R, Tilgen W: Dermatologische Onkologie. Berlin: Springer Verlag, 1997: 369-386.
5. Gonzalez Gonzalez D, van Dijk JD, Blank LE, Rumke P. Combined treatment with radiation and hyperthermia in metastatic malignant melanoma. Radiother Oncol 1986; 6: 105-113.
6. Falk MH, Issels RD. Hyperthermia in oncology. Int J Hyperthermia 2001; 17/1: 1-18.
7. Overgaard J, Gonzalez Gonzalez D, Hulshof MCCM, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345:540-543.
8. Karrer S, Szeimies RM, Hohenleutner U, Landthaler M. Role of lasers and photodynamic therapy in the treatment of cutaneous malignancy. Am J Clin Dermatol 2001; 2: 229-237,
9. Oratz R, Hauschild A, Sebastian G, Schadendorf D, Castro D, Broecker EB, Orenberg EK. Intratumoral cisplatin/adrenaline injectable gel for the treatment of patients with cutaneous and soft tissue metastases of malignant melanoma. Melanoma Res 2003; 13: 59-66.
10. Wolf IH, Smolle J, Binder B, Cerroni L, Richtig E, Kerl H. Topical imiquimod in the treatment of metastatic melanoma to skin. Arch Dermatol 2003; 139: 273-276.
11. Wolf IH, Richtig E, Kopera D, Kerl H. Loco-regional cutaneous metastases of malignant melanoma and their management. Dermatol Surg, in press.
12. Balch Ch, Buzaid A, Atkins M, Cascinelli N, Coit D, Fleming I, Houghton Jr A, Kirkwood J, Mihm M, Morton D, Reintgen D, Ross M, Sober A, Soong SJ, Thompson J, Thompson J, Gershenwald J, McMasters K. A new American Joint Committee on Cancer Staging System for Cutaneous Melanoma. Cancer 2000; 88: 1484-1491.
13. Kim JH, Hahn EW, Tokita N. Combination hyperthermia and radiation therapy for cutaneous malignant melanoma. Cancer 1978; 41: 2143-2148.
14. Kim JH, Hahn EW, Ahmed SA. Combination hyperthermia and radiation therapy for malignant melanoma. Cancer 1982; 50: 478-482.
15. Vrouenraets BC, Hart GA, Eggermont AM, Klaase JM, van Geel BN, Nieweg OE, Kroon BBR. Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. J Am Coll Surg 1999; 188(5): 522-530.
16. Tominaga R, Nakano T, Shibata S, Siraishi K, Nagae S, Nakayama J, Yasui H. Systemic effects of hyperthermic isolated lower limb perfusion with carboplatin and interferon-S. Artif Organs 2001; 25(1): 36-41.
17. Frick S, Lischner S, Rosien F, Haacke TC, Schaefer F, Christophers E, Hauschild A. Temozolomid als Therapieoption bei Patienten mit fernmetastasiertem Melanom und ungünstiger Prognose. Hautarzt 2002; 53: 659-665.
18. Serrone L, Zeuli M, Sega FM, Cognet-ti F. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview. J Exp Clin Cancer Res 2000; 19(1): 21-34.
19. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom A, Christian M, Gwyther S. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst; 2000: Vol. 92/3, Feb 2, 205-216.
20. Kubota N, Kakehi M, Inada T. Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids. Int J Rad Oncol Biol Phys 1993;25:491-497.
21. Kusumoto T, Maehara Y, Baba H, Takahashi I, Kusumoto H, Ohno S, Sugimachi K. Sequence dependence of the hyperthermic potentiation of carboplatin-induced cytotoxicity and intracellular platinum accumulation in HeLa cells. Brit J Cancer 1993; 68: 259-263.
22. Blochl-Daum B, Müller M, Meisinger V, Eichler HG, Fassolt A, Pehamberger H. Measurement of extracellular fluid carboplatin kinetics in melanoma metastases with microdialysis. Br J Cancer 1996; 73 (7): 920-924.
23. Wagstaff AJ, Ward A, Benfield P, Heel RC. Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs 1989; 37: 162-190.
24. Evans LM, Casper ES, Rosenbluth R. Phase II trial of carboplatin in advanced malignant melanoma. Cancer Treat Rep 1987 Feb; 71(2): 171-172.
25. Güven K, Kittler H, Wolff K, Pehamberger H. Cisplatin and carboplatin combination as second-line chemotherapy in dacarbazine-resistant melanoma patients. Melanoma Res 2001; 11(4): 411-415.
26. Becker JC, Kaempgen E, Broecker EB. Klassische Chemotherapie des metastasierenden Melanoms. Z Hautkr 2000; 9: 553-558.
27. Wendtner CM, Hallek M, Schmid Wendtner MH. Medikamentöse Therapie bei Fernmetastasierung. In: Volkenandt M, Plewig G: Empfehlungen zur Diagnostik, Therapie und Nachsorge maligner Melanome. Tumorzentrum München. 5. Auflage. München: Zugschwerdt, 2000: 65-71.
28. Walsh P, Gibbs P, Gonzalez R. Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease. J Am Acad Dermatol 2000; 42: 480-489.
29. Barth A, Wanek LA, Morton DL. Prognostic factors in 1,521 melanoma patients with distant metastases. J Am Coll Surg 1995; 181: 193-201.
30. Garbe C, Schaumburg-Lever G. Klinik und Histologie des malignen Melanoms. In: Garbe C, Dummer R, Kaufmann R, Tilgen W: Dermatologische Onkologie. Berlin: Springer Verlag, 1997:247-270.